Prawo i regulacje · 29/08/2005

DEA Extends Comment Period for Embutramide Scheduling

The Drug Enforcement Administration (DEA) is extending the comment period and time to request a hearing on a proposed rulemaking regarding the scheduling of Embutramide into Schedule III, originally published on July 29, 2005.